chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1 BIG BLOOD CLOT IN LEFT LUNG/LITTLE ONES (CLOTS) IN RIGHT LUNG; This spontaneous report received from a patient via a company representative via medi concerned a patient of an unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient previously received covid-19 vaccine ad26.cov2.s  (unspecified manufacturer) (dose number in series 1) (suspension for injection, route of admin, and batch number were not reported) dose, 01 total, start therapy date were not reported for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin, and batch number were not reported) dose, 01 total, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, 8 months after vaccination, the patient had to go to ER (emergency room). The patient experienced 1 big blood clot in left lung and little ones (clots) in right lung and was hospitalized (dose number in series 2). The number of days hospitalized was 5. It was reported that, "I had 2 shots.8 mo after I had to go to ER.Had 1 big blood clot in left lung and little ones in right lung.Said it was 1 side effect of the shot. 5 days in hospital." The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of 1 big blood clot in left lung/little ones (clots) in right lung was not reported. This report was serious (Hospitalization Caused / Prolonged). This case is a duplicate of 20221236007, 20221236261 and 20221236691.  It was determined that 20221236007, 20221236261 and 20221236691 was a duplicate of this case. All relevant information regarding this case will be submitted under 20221236114.; Sender's Comments: V0:20221236114- 1 big blood clot in left lung/little ones (clots) in right lung . The event has an unknown/unclear temporal relationship, and is labeled. There is no information on any other factors potentially associated with the event. Therefore, this event is considered consistent with vaccine administration.
The pt was seen in the ER on 1/17/01 with a rash and swelling. Was given Benadryl. Was seen in the clinic on 1/18/01 with isolated erythemic diffuse rash on right inner thigh and inguinal region. Given Atarax and cortaid cream. Pt also had acute gastroenteritis.
He is still experiencing headache; Cough; Muscle aches; He is still experiencing fatigues; he is still experiencing body aches; This is a spontaneous report from a contactable consumer (patient) or other non-health care professional. A 60-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0158) via an unspecified route of administration, administered in left arm on 08Apr2021 09:00 (at the age of 60-year-old) as dose 2, single for covid-19 immunization. Medical history included ongoing blood pressure, High blood pressure, started about 7 yrs ago. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (solution for injection, Lot Number: EP7534) via injection, administered in left arm on 18Mar2021 as dose 1 single for COVID-19 immunization. No vaccine Administered at Facility. On 09Apr2021 the patient experienced muscle aches, he was still experiencing fatigues on 10Apr2021 he was still experiencing headache, cough on an unspecified date in Apr2021 he was still experiencing body aches. It was reported that patient got his second dose last thursday. The day after he had muscle aches.  The day after that, he had symptoms of headache, muscle ache, fatigue, and then a cough through the night as his chest hurt.  He had fatigue the next day. His muscle aches and fatigue had gotten a little better, despite the last 2 days.  Caller is asking if he is contagious if he is around another person. The muscle ache comes and goes, they re improving, but it gets better than worse.  The headache is not as bad as that. Caller received his second dose on 8Apr2021, LOT number EW0158, left arm injection at 09:00.  He received both doses at about the same time of day. The AEs does not required a visit to emergency room and physician office. No AE(s) prior vaccination. Outcome of the events muscle aches, he was still experiencing fatigues were resolving, outcome of the events he was still experiencing headache was resolved on 11Apr2021 and Cough was resolved on 10Apr2021 and outcome of the event he was still experiencing body aches was unknown.  No follow-up attempts are needed. No further information is expected.
with small amounts of blood in vomit; Pain in right arm; back and head ache; back and head ache; nausea; vomiting; This is a spontaneous report from a contactable consumer (patient). A 25-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the right arm on 10Apr2021 at 13:15 (lot number and expiration date: unknown) at a single dose for COVID-19 immunization. Medical history was not reported. Concomitant medication included fluoxetine (FLUOXETINE) taken for an unspecified indication, start and stop date were not reported. The patient had known allergies with Nyquil. The patient had no other vaccine in four weeks, had no COVID prior to vaccination and was not tested post vaccination. The patient experienced pain in right arm, back and head ache, nausea and vomiting, with small amounts of blood in the vomit on 11Apr2021 at 02:00. No treatment was administered for the events. The events were resolving at the time of the report.  Information about lot/batch has been requested.
itching at the injection site; red at the injection site; redness is less but cover more space; red size like a 2 silver dollar coin; A spontaneous report was received from a Consumer concerning a 84 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced red size like a 2 silver dollar coin, red at the injection site, itching at the injection site, redness is less but cover more space.  The patient's medical history was not provided. The patient took blood pressure pills, cholesterol pills, Nexium, vitamins, allergies pills as concomitant medication.    On 15-01-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 batch no: 013L20A intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 16-01-2021, The patient experienced red size like a 2 silver dollar coin.  On 27-01-2021, the patient experienced red at the injection site, itching at the injection site, redness is less but cover more space. Laboratory details are not provided.  The patient put Benadryl as the treatment medication.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events red size like a 2 silver dollar coin, red at the injection site, itching at the injection site, redness is less but cover more space is unknown.
Information was considered medically important. Information regarding PREVNAR was received from a pediatrician regarding a male patient (under the age of 5 years) who experienced bacteremia from invasive pneumococcal disease - drug ineffective. The patient received the first dose, second dose, third dose and fourth dose of unspecified dates. Relevant medical history was not provided. It was reported that the 4 doses of product had been administered on unknown dates. Each dose was 1 dose 1 time per day (intramuscular). Concomitant medications were not reported. The patient experienced bacteremia from invasive pneumococcal disease (drug ineffective) on an unknown date in 2007. The serotype was unknown. The patient's parents stated that the child's immunizations were current. However, the physician explained that the patient had been previously cared for by an Health Services Hospital, therefore he could not confirm that the patient had received all 4 doses of PREVNAR. It was unknown if bacteremia was resolved. No additional information was available at the time of this report.
I started feeling unusual inflammation in my body. I had a whole lot of pressure in my lower abdomen. I noticed on the right side of my groin there were multiple swollen glands. The inflammation was across my chest and all over my torso. I felt fatigue. The biggest thing was the swollen glands. I waited 3 weeks before seeing my doctor. She said to come back in 2 weeks if they were still there, so I went back in 2 weeks. She ruled everything out that she tested for. They did a CT scan of my abdomen. They said it was a swollen response from the vaccine. After a couple more weeks, it finally went away.
I felt out of body like I could not focus for the first day; increasingly more and more dizzy and put off it; I was also exhausted and could barely do anything; havent been able to work since I got the vaccine; This is a spontaneous report from a contactable consumer (patient). A 37-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: En6203), via an unspecified route of administration in the left arm on 26Apr2021 at 13:30 (at the age of 37-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had tested for COVID-19. The patient stated that on 26apr2021 14:00, she felt out of body like she could not focus for the first day and then increasingly more and more dizzy and put off it. She was also exhausted and could barely do anything, ended up in urgent care and then the ER. She had not been able to work since she got the vaccine and still struggle everyday with her energy and cognitive levels. The events were assessed to be serious (Disabling/Incapacitating). The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent sars-cov-2 test: negative on 06May2021. The patient received treatment for the events. The clinical outcome for events was recovering.
It appears 15 month old who was suppose to get Dtap- received Tdap- lot # for vaccine as recorded in chart was for Tdap although Dtap recorded as immunization given. No adverse reaction.
Woke up the next morning not feeling at all myself - overly tired, body ache, headache, fever (101 at highest), nausea.  Took baby aspirin (4-5 chewed up) for arm pain and body aches.  Fever lasted 24 hours.  Body aches, feeling tired lasted 3 days and mild headache lasted 7 days.  Sore arm lasted 7 days.
PAIN AT INJECTION; This spontaneous report received from a patient concerned a 58 year old male. The patient's weight was 130 pounds, and height was 64 inches. The patient's concurrent conditions included non smoker, and no alcohol use, and other pre-existing medical conditions included the patient had no known allergies and had no history of drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 2018218, expiry: 23-JUN-2021) dose was not reported, administered on 20-MAY-2021 for prophylactic vaccination. Concomitant medications included bnt 162 for prophylactic vaccination. On 20-MAY-2021, the subject experienced pain at injection. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pain at injection on 20-MAY-2021. This report was non-serious.
injection site swelling; injection site redness; injection site heat/ heat to touch from shoulder to elbow; This case was reported by a pharmacist via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 71-year-old female patient who received Herpes zoster (Shingrix) (batch number Z9E99, expiry date 2nd June 2021) for prophylaxis.   On 6th May 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced extensive swelling of vaccinated limb, erythema and skin warm. On an unknown date, the outcome of the extensive swelling of vaccinated limb, erythema and skin warm were unknown.   It was unknown if the reporter considered the extensive swelling of vaccinated limb, erythema and skin warm to be related to Shingrix.  Additional details were provided as follows: The patient continued to experience overall redness, swelling and heat to touch from shoulder to elbow after vaccination with Shingrix almost one month ago, from the date of reporting.
Feeling bad; Was the 2nd moderna shot mad at me; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling bad) and VACCINATION COMPLICATION (Was the 2nd moderna shot mad at me) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Feeling bad) and VACCINATION COMPLICATION (Was the 2nd moderna shot mad at me). At the time of the report, FEELING ABNORMAL (Feeling bad) and VACCINATION COMPLICATION (Was the 2nd moderna shot mad at me) outcome was unknown. Not Provided          No Concomitant medications were provided  No treatment medications were provided.
Break through vaginal bleeding for 2-4 days per month for two months/Vaginal bleeding during sex the second month following the second dose; This is a spontaneous report from a contactable consumer (patient). A 45-years-old non-pregnant female patient received BNT162b2 (Pfizer BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number: EW0180 and Expiration date was not reported), via an unspecified route of administration, administered in right arm on 09Jun2021 at 10:45 hours (at the age of 44-years-old) as dose 2, single for COVID-19 immunization. The patient medical history included COVID-19 (prior to vaccination) from an unknown date and unknown if ongoing. The patient previously took cefazolin and metoclopramide hydrochloride (Reglan) and had allergy to cefazolin and metoclopramide hydrochloride (Reglan). Historical vaccine included patient received BNT162b2 (Pfizer BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number: EW0185 and Expiration date was not reported), via an unspecified route of administration, administered in left arm on 19May2021 at 16:00 hours (at the age of 44-years-old) as dose 1, single for COVID-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had not been tested for COVID-19, since the vaccination. Concomitant medication(s) patient received within 2 weeks of vaccination included cetirizine hydrochloride (Zyrtec), mometasone furoate (Nasonex), montelukast sodium (Singulair), omeprazole (Prilosec) (all taken for an unspecified indication, start and stop date were not reported). On 12Jul2021 at 14:00 hours, patient experienced break through vaginal bleeding for 2-4 days per month for two months following the second vaccine/vaginal bleeding during sex the second month following the second dose. Patient had physician office visit for the events. Patient received no treatment for the events. The outcome for the event was recovered on unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
4/15/2021: Body aches, mild fever, mild headache. 4/18/2021: Light-headed, chest pain, shortness of breath, rapid pulse, dizziness, higher than normal blood pressure. (Normal for me is 100/70. Pressure was 150/90)
raised vesicle/pustule with raised erythematous base appeared at intradermal injection site at left lower forearm approx 18 hours after vaccine administration and persist 44 hours after.  By photo the lesion appears to be approx 0.5 cm diameter with mild erythema of surrounding area approx 2 cm diameter. Patient reports mild pruritis, denies pain. Denies systemic symptoms.
very sore arm headache body aches chills low grade fever (100.3) All began approximately 12 hours after the vaccine was administered.  As of this submission, it has only been approximately 16 hours since I received the vaccine.  I am currently experiencing the listed symptoms.  Given that, there is no information to provide for Item 21, below.
No additional adverse efect reported; PROQUAD that underwent a temperature excursion was administered.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 17-FEB-2021, the patient was vaccinated with improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live, recombinant Human albumin (rHA) (PROQUAD) lot # T027115, expiration date 07-FEB-2022 (exact dose, route of administration and anatomical location were not provided) for prophylaxis. Administered dose of vaccine experienced the temperature excursion from -10 degrees Celsius to 8 degrees Celsius (-3.7 degrees Celsius) for 22 hours. There was no previous temperature excursion. Data logger was involved. There was no additional adverse effect reported.
Patient reported having a lump in her throat and feeling anxious Patient seen by medical team and vitals were stable  Patient refused medical transfer and signed AMA form Patient stated symptoms improved
Developed approx 3 vesicular lesions left arm 3 days after vaccination. Developed mild widespread papular rash that spread from days 5-12 after vaccination. Treating with supportive care.
Fine red rash on Abdomen, arms, itchy, with a burning sensation. T 96.7, P72, Resp 20, B/P 118/72 Wt 145.
Confusion, Depression, Dizziness, Headache, NauseaVomiting, LEFT ARM AND HAND NUMBNESS TINGLING, JOINT PAIN, FATIGUE Narrative: LOST WORK TIME
severe pain, neurotemperature,  issues, hard time swallowing, heart palpatations, chest tightness, severe nerve pain
Pt has multiple comorbidities. In addition called to request off label live vaccine (out of recommended age range). Complained of paralysis in arm from vaccine 1 yr ago.
I started experiencing post nasal drip which I didn't have before covid jab. Then it got worse and it seems to be catarrh. When I bow my head down to wash my face, base of my throat is completely blocked and I can't breath. Mucus has become constant, uncoloured, non-smelly but thick mostly coming from throat. I have been prescribed a nasal spray, I sleep propped-up, drink a lot of water all throughout the day but it would not go away.
This spontaneous report was received from an unspecified reporter referring to unknown number of female patients of unknown ages. Information about concomitant medication, pertinent medical history and drug reactions was not provided. On an unknown date the patients were vaccinated with GARDASIL 9 for prophylaxis (strength, dose, frequency, route, lot # and expiration date were not reported). The reporter stated the patients all over were being devastated by GARDASIL 9, and that the GARDASIL 9 was killing as many people as it wanted (death). The reporter considered death to be related to GARDASIL 9. It was unknown if autopsy was done. This is one of two reports received from the same reporter.; Sender's Comments: US-009507513-1810USA010304:
This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (sore arm) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced pain in extremity (sore arm). At the time of the report, pain in extremity (sore arm) outcome: unknown/not provided. Concomitant product used included high blood pressure medication (NOS). Treatment information not provided. This case linked to MOD-2021-200424 (patient link). Reporter did not allow further contact.
Left deltoid pain (site of injection); fever, chills, body aches which lasted 3 days; as these resolved, the right ankle began swollen and painful to the point he had difficulty bearing weight, now the left ankle is swollen.
Swollen Armpit and pain/discomfort in armpit along with radiating ache in chest and back. possibly some heart palpitations not sure if it's related.
Vaccine was stored in the freezer instead of the fridge and given to the patient, no adverse reactions have been reported after administration.
Headache, nauseous, ache (but not severe), gas/belching.  I vomited once.  This lasted about 2 hours after waking up. Tired and no appetite all day. My vaccine was 4:30p and the next day I was fine. My adverse reaction was the 2nd day. My vaccine site was only sore to touch but red-about the size of a 50 cent piece. Day 4 and the redness is not as bad but still there.
Mother of the pt stated she and her daughter received the flu shot administered by the FD on 10/13/2017. Mother stated the pt told her later that evening her arm was sore. Mother stated when they woke up on Saturday morning  she noticed her daughters arm was swollen and very red. Mother stated the area where the shot was administered was hard and raised. Mother stated later that afternoon she noticed the redness was spreading to her entire upper arm. Mother received some advice from a neighbor about drawing a line around the area, and if the redness spreads to go to the clinic. Mother did so and also administered one dose of over the counter benadryl to her daughter.  Sunday morning the redness and swelling had moved beyond the drawn line. Mother took her daughter to a walk in clinic. The staff physician prescribed amoxacillin and prednisone. Mother was told to follow up with their normal family physician. Mother stated when called by agency days later that her daughter had completely recovered. She stated she has not followed up with her normal physician.
PATIENT REPORTS SHINGLES BREAKOUT ON RIGHT ARM 2 TO 3 DAYS FOLLOWING VACCINE.  THIS IS NOT THE ARM VACCINE WAS GIVEN IN.  PATIENT STATES HAVING RECEIVED ZOSTAVAX IN THE PAST AND ALSO HAVING 2 CASES OF ACTIVE SHINGLES.  THE CURRENT 'BUMPS' ARE BURNING AND STINGING.  PATIENT SAYS THE RASH IS TOLERABLE AND DOES NOT PLAN TO SEE HER PHYSICIAN.  SHE HAS APPLIED HYDROCORTISONE TO THE AREA WHICH HAS HELPED.  THIS RASH IS AT A DIFFERENT LOCATION THAN THE PREVIOUS 2 CASES OF SHINGLES.
hair falling out in clumps; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (hair falling out in clumps) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Alopecia (Taken steroid shots which helped in hair growth) in February 2020.    In March 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (hair falling out in clumps). At the time of the report, ALOPECIA (hair falling out in clumps) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.  Concomitant medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow-up information received on 03-jun-2021 contains no new information.
patient stated that when given the 1first dose she had numbness in her throat. and it also occurred with the second dose